Rho-Kinase Inhibitors for the Treatment of Refractory Diabetic Macular Oedema

Diabetic macular oedema (DMO) is one of the leading causes of vision loss associated with diabetic retinopathy (DR). New insights in managing this condition have changed the paradigm in its treatment, with intravitreal injections of antivascular endothelial growth factor (anti-VEGF) having become th...

Descripció completa

Dades bibliogràfiques

Autors principals:	Milagros Mateos-Olivares, Luis García-Onrubia, Fco. Javier Valentín-Bravo, Rogelio González-Sarmiento, Maribel Lopez-Galvez, J. Carlos Pastor, Ricardo Usategui-Martín, Salvador Pastor-Idoate
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2021-07-01
Col·lecció:	Cells
Matèries:	diabetic macular oedema diabetic retinopathy macular oedema rho-associated kinases
Accés en línia:	https://www.mdpi.com/2073-4409/10/7/1683
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!